Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK). - Test2 - elhamkhani - TriplyDB

Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK).

Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK).

http://www.wikidata.org/entity/Q41872337

about

Genome of the opportunistic pathogen Streptococcus sanguinis Crystal structure of enoyl-acyl carrier protein reductase (FabK) fromStreptococcus pneumoniaereveals the binding mode of an inhibitor Structure of the Yersinia pestis FabV Enoyl-ACP Reductase and Its Interaction with Two 2-Pyridone Inhibitors Structural and Enzymatic Analyses Reveal the Binding Mode of a Novel Series of Francisella tularensis Enoyl Reductase (FabI) Inhibitors Resistance Mechanisms and the Future of Bacterial Enoyl-Acyl Carrier Protein Reductase (FabI) Antibiotics Using modern tools to probe the structure-function relationship of fatty acid synthases Antibacterial targets in fatty acid biosynthesis Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase Triclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase Postgenomic strategies in antibacterial drug discovery.Screening of metagenomic and genomic libraries reveals three classes of bacterial enzymes that overcome the toxicity of acrylate.Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors.The MUT056399 inhibitor of FabI is a new antistaphylococcal compound.Identification of a conserved protein involved in anaerobic unsaturated fatty acid synthesis in Neiserria gonorrhoeae: implications for facultative and obligate anaerobes that lack FabA.Is bacterial fatty acid synthesis a valid target for antibacterial drug discovery?FabV/Triclosan Is an Antibiotic-Free and Cost-Effective Selection System for Efficient Maintenance of High and Medium-Copy Number Plasmids in Escherichia coli.Crystallization and preliminary X-ray crystallographic studies of a new class of enoyl-(acyl-carrier protein) reductase, FabV, from Vibrio fischeri Mutations associated with reduced surotomycin susceptibility in Clostridium difficile and Enterococcus species Ralstonia solanacearum fatty acid composition is determined by interaction of two 3-ketoacyl-acyl carrier protein reductases encoded on separate replicons.Differences in antibiotic-induced oxidative stress responses between laboratory and clinical isolates of Streptococcus pneumoniae.Expression, purification and characterization of enoyl-ACP reductase II, FabK, from Porphyromonas gingivalis.Inhibiting bacterial fatty acid synthesis.Plasmid selection in Escherichia coli using an endogenous essential gene marker.Proteomic analysis of oil body membrane proteins accompanying the onset of desiccation phase during sunflower seed development Selectivity of Pyridone- and Diphenyl Ether-Based Inhibitors for the Yersinia pestis FabV Enoyl-ACP Reductase.Regulation of fatty acid metabolism in bacteria.A Pathogen-Selective Antibiotic Minimizes Disturbance to the Microbiome.Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.The two functional enoyl-acyl carrier protein reductases of Enterococcus faecalis do not mediate triclosan resistance Transcriptional regulation in bacterial membrane lipid synthesis.Diversity in enoyl-acyl carrier protein reductases.Resistance to AFN-1252 arises from missense mutations in Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI).Enoyl-Acyl Carrier Protein Reductase I (FabI) Is Essential for the Intracellular Growth of Listeria monocytogenes.Bacterial fatty acid synthesis and its relationships with polyketide synthetic pathways.Inefficient translation renders the Enterococcus faecalis fabK enoyl-acyl carrier protein reductase phenotypically cryptic Enoyl acyl carrier protein reductase inhibitors: a patent review (2006 - 2010).Recent advances in inhibitors of bacterial fatty acid synthesis type II (FASII) system enzymes as potential antibacterial agents.Fatty acid biosynthesis revisited: structure elucidation and metabolic engineering.Bacterial fatty acid metabolism in modern antibiotic discovery.Improved triclosan delivery by a novel silica-based nanocomposite.

P2860

Q24680395-99983378-09A7-4108-88E3-8D3A0FF5942C Q27649956-D69A2ED8-39BD-4045-9477-949C5688BA11 Q27676726-6B2D2A9C-F4A7-4F49-B5FC-CE78E2B9D85C Q27679331-99E9D880-E142-4E9B-B78F-D520F1F310FD Q28069943-271F92A8-23C5-4B9C-BCDF-EB93A9D51FA0 Q28080940-5263EFB1-D051-49E6-8D6C-D1B214A69BF6 Q28241394-5807BE25-AD30-49EE-840B-EC47B643C0D4 Q28485714-C4289B75-4E3A-4E1F-8420-282C8777A974 Q28492833-3571CDD8-B8E1-404B-871F-14726FDCEBEC Q33745572-D0A36BA8-DC31-4030-93E7-B066ADB1D44B Q35171952-403AFF95-980A-4979-8CA8-0654D920A457 Q35216999-27251AFF-4EF2-4D5E-A778-AC8CB4BF6076 Q35270339-4DB89205-2C8A-4AB0-889C-1AFF3C552D0E Q35332481-AF2A6B85-F9E5-4DA6-A6EF-C852927A0F69 Q35350186-C2EF0E00-D991-4614-9A3E-C4BDADD587EA Q35657979-D23E8A89-D11B-49EE-81D6-7E71BEB18323 Q35660984-59A84CF6-ED5A-479A-A9CC-1C31E3787C92 Q35746268-61DB4F9A-B87C-4C3A-941A-37AEF536163B Q35816769-4522BE2E-72B9-4CD8-A054-BB7A87221CF5 Q35960925-C7B1445C-1A32-40B9-9B92-846770BB2EB8 Q36203279-8D4CDC78-F21F-4E30-879D-2B42684233D1 Q36464020-9E7C113E-64BF-4F1F-AC60-556267B90FF9 Q36856568-A7C1336E-7C93-459A-945A-54FD3B147FAD Q36862207-B5B183D2-B95A-41A8-A554-01546760251F Q36951981-E1B5A36C-AD50-4E50-A495-93FF6C45FF4C Q36962272-68F89CCF-244F-4A92-8E18-30AC843863A0 Q37023140-104838A3-0FBD-469F-8E57-5405DBD531CE Q37128281-C29C1936-6E3D-4324-916E-F62D3AF7B98F Q37218845-7844CD37-4152-4D4F-9F48-0316BC9DB569 Q37305233-223B1B4C-1FA9-485F-BB15-0D684E94825C Q37371673-622EC69D-91B6-4CCE-B344-0321CF9C4DC1 Q37404976-56EF052A-A6AB-4C7F-AD3F-5C2164E083BB Q37425029-9BE985DD-28EB-4239-904B-616A327F2B77 Q37442104-C9657AAF-073B-4B04-8C78-0C2B252FBF7A Q37545596-CB3472A1-A1D9-4413-8D31-91DEC5E584CB Q37886187-FDB8C176-FD34-4ED7-930D-EA334E0B61BA Q38124842-62377F53-87C4-4F8D-9BE1-2981C064C955 Q38264138-B44EB644-9037-4EB0-98E4-0AFA2ACC2882 Q38964523-390FC868-7E90-4B3C-8CBB-5206545AC05D Q39237824-28DF3BD8-95FC-4A50-AA6C-61EC1BEE825D

P2860

Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK).

http://www.wikidata.org/entity/Q41872337

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Characterization of Streptococ ...... ier protein) reductase (FabK).

@en

type

label

Characterization of Streptococ ...... ier protein) reductase (FabK).

@en

prefLabel

Characterization of Streptococ ...... ier protein) reductase (FabK).

@en

P1433

Q41872337-91DBEE84-CAB6-45E3-B004-CD53594A4C3B

P1476

Q41872337-30999D42-B1D6-41FF-8DA6-3F86911E7563

P2093

Q41872337-174517F0-F043-4804-A534-300C0EB7019B

Q41872337-3E358FF8-20CF-43AF-820F-77CB1343B2B8

Q41872337-3E64F7F3-3845-4738-8455-25295156420D

Q41872337-42B7D2AF-97E7-4480-9CC3-762BFCA6217A

Q41872337-6793484B-8BCE-4606-A8E0-C990997D7766

Q41872337-69975F9D-C9F1-4ABD-84CE-37E42D843B02

Q41872337-6FFF40DD-2BF0-4C11-8321-0356C538285A

Q41872337-7A2F714E-EB0C-4765-BAC1-9EC96771763D

Q41872337-8235ACD5-82AB-407D-9F4B-38B0788303DE

Q41872337-96A0CDE6-E972-444C-9F08-E6FF101058C3

P2860

Q41872337-0589A4DE-913D-49FE-83DB-E2ED6DAD778D

Q41872337-11E58400-F65F-4C8E-814B-1BF92EAEACD9

Q41872337-15696A31-5E0F-410D-989C-2F3E9EA8F840

Q41872337-2B18B823-1B91-4B2F-9BA8-C86FE0B0A4D4

Q41872337-2B9D75BA-4119-4692-BD16-00ABD589D9C4

Q41872337-2E152DA7-00AD-451B-8E54-0C06C74DE303

Q41872337-30BD9732-8A73-4432-9661-CA7AD58C718D

Q41872337-4059DD91-EA8C-4CC5-87F7-C23A9780BCFF

Q41872337-510AEC6C-38B2-4F8A-81BC-5B1E5134A498

Q41872337-5265F856-4576-45B4-B14F-A0EDF117ED96

P304

Q41872337-3BEDC5D4-5AED-44EB-AEB2-8BC56A027680

P31

Q41872337-50E531E6-E86C-4AE6-9698-291FDDFCF4F1

P356

Q41872337-3D14E6AF-D141-410D-BFB9-0F195A16B104

P407

Q41872337-D3374E74-0A8F-4980-AF79-C697D2C91C19

P433

Q41872337-B61665EA-1E64-4971-AD16-7CDCA3F6E27A

P478

Q41872337-8B930550-184E-48C9-A4AD-DCE336F05FE1

P577

Q41872337-9B0FCADF-8349-4B90-A97B-944F72FF8973

P5875

Q41872337-CC0947E6-CB11-451B-A3AC-544F8A6196F4

P698

Q41872337-41501701-4A9C-4A99-9C5A-D04524B110D9

P932

Q41872337-939E122E-40B7-428C-9BAF-6F345E11F9A2

P356

P1433

Biochemical Journal

P1476

Characterization of Streptococ ...... ier protein) reductase (FabK).

@en

P2093

Brian J Polizzi

http://www.w3.org/2001/XMLSchema#string

Chad Quinn

http://www.w3.org/2001/XMLSchema#string

Charles O Rock

http://www.w3.org/2001/XMLSchema#string

Chi Y So

http://www.w3.org/2001/XMLSchema#string

David J Holmes

http://www.w3.org/2001/XMLSchema#string

David J Payne

http://www.w3.org/2001/XMLSchema#string

Hedia Marrakchi

http://www.w3.org/2001/XMLSchema#string

Joshua West

http://www.w3.org/2001/XMLSchema#string

Nicola G Wallis

http://www.w3.org/2001/XMLSchema#string

Richard J Heath

http://www.w3.org/2001/XMLSchema#string

P2860

An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan

Inhibitor binding studies on enoyl reductase reveal conformational changes related to substrate recognition

Crystallographic analysis of triclosan bound to enoyl reductase

Mechanism of triclosan inhibition of bacterial fatty acid synthesis

Triclosan targets lipid synthesis

Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene

The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis

Contribution of NADH oxidase to aerobic metabolism of Streptococcus pyogenes.

P304

1055-1062

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/BJ20021699

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 3

http://www.w3.org/2001/XMLSchema#string

P478

370

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10985549

http://www.w3.org/2001/XMLSchema#string

P698

12487627

http://www.w3.org/2001/XMLSchema#string

P932

1223239

http://www.w3.org/2001/XMLSchema#string